OLMA - Olema Pharmaceuticals director discloses sale of 25000 shares
2023-10-04 10:52:02 ET
More on Olema Pharmaceuticals
- Olema: Two-Pronged Approach To Treat Breast Cancer Patients
- Olema: Contrarian Small Cap Oncology Biotech (Reiterating Buy)
- Olema Pharmaceuticals up 6% on $180M financing
- Seeking Alpha’s Quant Rating on Olema Pharmaceuticals
- Historical earnings data for Olema Pharmaceuticals
For further details see:
Olema Pharmaceuticals director discloses sale of 25,000 shares